136 related articles for article (PubMed ID: 31511935)
1. Integrating physiologically based kinetic (PBK) and Monte Carlo modelling to predict inter-individual and inter-ethnic variation in bioactivation and liver toxicity of lasiocarpine.
Ning J; Rietjens IMCM; Strikwold M
Arch Toxicol; 2019 Oct; 93(10):2943-2960. PubMed ID: 31511935
[TBL] [Abstract][Full Text] [Related]
2. Use of an in vitro-in silico testing strategy to predict inter-species and inter-ethnic human differences in liver toxicity of the pyrrolizidine alkaloids lasiocarpine and riddelliine.
Ning J; Chen L; Strikwold M; Louisse J; Wesseling S; Rietjens IMCM
Arch Toxicol; 2019 Mar; 93(3):801-818. PubMed ID: 30661089
[TBL] [Abstract][Full Text] [Related]
3. Development of a Combined In Vitro Physiologically Based Kinetic (PBK) and Monte Carlo Modelling Approach to Predict Interindividual Human Variation in Phenol-Induced Developmental Toxicity.
Strikwold M; Spenkelink B; Woutersen RA; Rietjens IMCM; Punt A
Toxicol Sci; 2017 Jun; 157(2):365-376. PubMed ID: 28498972
[TBL] [Abstract][Full Text] [Related]
4. Inter-individual variation in chlorpyrifos toxicokinetics characterized by physiologically based kinetic (PBK) and Monte Carlo simulation comparing human liver microsome and Supersome
Zhao S; Wesseling S; Rietjens IMCM; Strikwold M
Arch Toxicol; 2022 May; 96(5):1387-1409. PubMed ID: 35294598
[TBL] [Abstract][Full Text] [Related]
5. In vitro-in silico-based prediction of inter-individual and inter-ethnic variations in the dose-dependent cardiotoxicity of R- and S-methadone in humans.
Shi M; Dong Y; Bouwmeester H; Rietjens IMCM; Strikwold M
Arch Toxicol; 2022 Aug; 96(8):2361-2380. PubMed ID: 35604418
[TBL] [Abstract][Full Text] [Related]
6. Use of physiologically based kinetic modelling-facilitated reverse dosimetry to convert in vitro cytotoxicity data to predicted in vivo liver toxicity of lasiocarpine and riddelliine in rat.
Chen L; Ning J; Louisse J; Wesseling S; Rietjens IMCM
Food Chem Toxicol; 2018 Jun; 116(Pt B):216-226. PubMed ID: 29634986
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the interindividual human variation in bioactivation of methyleugenol using physiologically based kinetic modeling and Monte Carlo simulations.
Al-Subeihi AA; Alhusainy W; Kiwamoto R; Spenkelink B; van Bladeren PJ; Rietjens IM; Punt A
Toxicol Appl Pharmacol; 2015 Mar; 283(2):117-26. PubMed ID: 25549870
[TBL] [Abstract][Full Text] [Related]
8. Study on inter-ethnic human differences in bioactivation and detoxification of estragole using physiologically based kinetic modeling.
Ning J; Louisse J; Spenkelink B; Wesseling S; Rietjens IMCM
Arch Toxicol; 2017 Sep; 91(9):3093-3108. PubMed ID: 28357488
[TBL] [Abstract][Full Text] [Related]
9. Prediction of in vivo genotoxicity of lasiocarpine and riddelliine in rat liver using a combined in vitro-physiologically based kinetic modelling-facilitated reverse dosimetry approach.
Chen L; Peijnenburg A; de Haan L; Rietjens IMCM
Arch Toxicol; 2019 Aug; 93(8):2385-2395. PubMed ID: 31289892
[TBL] [Abstract][Full Text] [Related]
10. Role of toxicokinetics and alternative testing strategies in pyrrolizidine alkaloid toxicity and risk assessment; state-of-the-art and future perspectives.
Ning J; Chen L; Rietjens IMCM
Food Chem Toxicol; 2019 Sep; 131():110572. PubMed ID: 31185270
[TBL] [Abstract][Full Text] [Related]
11. Monocrotaline-induced liver toxicity in rat predicted by a combined in vitro physiologically based kinetic modeling approach.
Suparmi S; Wesseling S; Rietjens IMCM
Arch Toxicol; 2020 Sep; 94(9):3281-3295. PubMed ID: 32518961
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Interindividual Human Variation in Bioactivation and DNA Adduct Formation of Estragole in Liver Predicted by Physiologically Based Kinetic/Dynamic and Monte Carlo Modeling.
Punt A; Paini A; Spenkelink A; Scholz G; Schilter B; van Bladeren PJ; Rietjens IM
Chem Res Toxicol; 2016 Apr; 29(4):659-68. PubMed ID: 26952143
[TBL] [Abstract][Full Text] [Related]
13. Development of an in vitro screening method of acute cytotoxicity of the pyrrolizidine alkaloid lasiocarpine in human and rodent hepatic cell lines by increasing susceptibility.
Forsch K; Schöning V; Disch L; Siewert B; Unger M; Drewe J
J Ethnopharmacol; 2018 May; 217():134-139. PubMed ID: 29454024
[TBL] [Abstract][Full Text] [Related]
14. A physiologically based in silico model for trans-2-hexenal detoxification and DNA adduct formation in human including interindividual variation indicates efficient detoxification and a negligible genotoxicity risk.
Kiwamoto R; Spenkelink A; Rietjens IM; Punt A
Arch Toxicol; 2013 Sep; 87(9):1725-37. PubMed ID: 23864024
[TBL] [Abstract][Full Text] [Related]
15. Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols.
Strikwold M; Spenkelink B; de Haan LHJ; Woutersen RA; Punt A; Rietjens IMCM
Arch Toxicol; 2017 May; 91(5):2119-2133. PubMed ID: 27815601
[TBL] [Abstract][Full Text] [Related]
16. 7-cysteine-pyrrole conjugate: A new potential DNA reactive metabolite of pyrrolizidine alkaloids.
He X; Xia Q; Ma L; Fu PP
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2016; 34(1):57-76. PubMed ID: 26761716
[TBL] [Abstract][Full Text] [Related]
17. A physiologically based kinetic modeling of ethyl tert-butyl ether in humans-An illustrative application of quantitative structure-property relationship and Monte Carlo simulation.
Watanabe-Matsumoto S; Yoshida K; Meiseki Y; Ishida S; Hirose A; Yamada T
J Toxicol Sci; 2022; 47(2):77-87. PubMed ID: 35110473
[TBL] [Abstract][Full Text] [Related]
18. Combining in vitro embryotoxicity data with physiologically based kinetic (PBK) modelling to define in vivo dose-response curves for developmental toxicity of phenol in rat and human.
Strikwold M; Spenkelink B; Woutersen RA; Rietjens IM; Punt A
Arch Toxicol; 2013 Sep; 87(9):1709-23. PubMed ID: 23943240
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of human interindividual variation in bioactivation of estragole using physiologically based biokinetic modeling.
Punt A; Jeurissen SM; Boersma MG; Delatour T; Scholz G; Schilter B; van Bladeren PJ; Rietjens IM
Toxicol Sci; 2010 Feb; 113(2):337-48. PubMed ID: 19920071
[TBL] [Abstract][Full Text] [Related]
20. Impact of in vitro experimental variation in kinetic parameters on physiologically based kinetic (PBK) model simulations.
Punt A; Bos P; Hakkert B; Louisse J
ALTEX; 2023; 40(2):237–247. PubMed ID: 35901496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
